BioTech Scout

Discover the most promising early-stage companies in life sciences, scouted by BioPharmaTrend. Follow company news and important business events.

back to Directory

RXi Pharmaceuticals Corporation

RXi Pharmaceuticals Corporation logo

Founded
2011
Patents
24
Clinical Trials
7
Publications
2

Technologies

RNA-focused Startups

RXi Pharmaceuticals Corporation (NASDAQ: RXII) is developing the next generation of immuno-oncology therapeutics based on its novel RNAi therapeutic platform including self-delivering RNAi (sd-rxRNA®) compounds.


Posts Mentioning This Company

Top Companies At The Forefront Of RNA Therapeutics Development

  
Alongside the topic of gene editing technologies that keeps making headlines these days, there is also a wave of breakthroughs in the field of RNA-targeting medicines, primarily falling into the following two categories: antisense oligonucleotides (ASO), and RNA interference (RNAi) technologies. (another promising approach, dealing with editing RNA itself by …